News
Discover the most recent news about our company
COVID-19 Hackathon #Endocrine Disruption, #Text mining in #Toxicology, #Bioinformatics #Metabolomics for #biomarker #discovey, #Organ-on-Chip testing… and more We have participated in the #OpenTox Virtual conference: https://www.opentox.net/events/virtual-conference-2020/program Our poster
Predicting the future of health
18 June 2020
Once infected by SARS-CoV-2, would you like to know your health status evolution? This is Biosfer Teslab commitment in the SARS-CoV-2 pandemic. The Spanish Institute of Health Research Pere…
Alberto Elzaburu Foundation award
8 November 2019
The sixth edition of the Alberto Elzaburu Foundation Innovation Award recognizes Núria Amigó, CEO of Biosfer Teslab, as a young entrepreneur The Alberto Elzaburu Foundation, for the sixth consecutive year,…
Biosfer Teslab presents its first industrial doctoral thesis
12 July 2019
The student Rocío Fuertes has obtained a doctoral degree from the University Rovira i Virgili after defending her thesis “1H-NMR glycoprotein analysis: An Advanced approach for Inflammatory diseases diagnosis”, for…
Disruptive innovations and start-ups
8 January 2019
Last December, Núria Amigó took part in the round table on “Disruptive innovations and start-ups”. You can see her speech here (video in Catalan)
LDL cholesterol: the poison is stored in small bottles
26 October 2018
Dr. Adriana Saltijeral of the University Hospital del Tajo (Aranjuez, Madrid) interviews Dr. Leopoldo Pérez de Isla, of the San Carlos Clinical Hospital of Madrid and member of the Scientific…
Standard values of number and size of lipoprotein particles per age and gender, using Nuclear Magnetic Resonance
27 July 2016
The XXIX Convention of the Spanish Atherosclerosis Society (SEA) took place in Granada last May, and its scientific committee chose another of the I+D projects developed in Biosfer Teslab to…
Metabolomics characterization for patients with Rheumatoid Arthritis using spectroscopy
22 July 2016
In May, the XXIX Convention of the Spanish Atherosclerosis Society (SEA) took place in Granada, and its scientific committee chose one of the I+D projects developed in Biosfer Teslab to…
Especialists ask for the use in clinical practise of the new Lipoprotein determination test
20 July 2016
Biosfer Teslab took part in the XXIX National Convention of the Spanish Atherosclerosis Society (SEA), held this past May. Specifically, the Liposcale test was the main topic of the Round…